Israel - Inggris - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Kanada - Inggris - Health Canada

adienne sa - thiotepa - powder for solution - 400mg - thiotepa 400mg

Singapura - Inggris - HSA (Health Sciences Authority)

axxessbio pte. ltd. - thiotepa - injection, powder, lyophilized, for solution - thiotepa 100mg/vial

Singapura - Inggris - HSA (Health Sciences Authority)

axxessbio pte. ltd. - thiotepa - injection, powder, lyophilized, for solution - thiotepa 15mg/vial

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - thiotepa 100mg - powder for injection - 100 mg - active: thiotepa 100mg - indicated, in combination with other chemotherapy medicinal products: - with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - thiotepa 15mg - powder for injection - 15 mg - active: thiotepa 15mg - indicated, in combination with other chemotherapy medicinal products: - with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - thiotepa 400mg - powder for injection with diluent - 400 mg - active: thiotepa 400mg excipient: sodium chloride water for injection - indicated, in combination with other chemotherapy medicinal products: - with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;

Amerika Serikat - Inggris - NLM (National Library of Medicine)

medisca inc. - ponazuril (unii: jpw84as66u) (ponazuril - unii:jpw84as66u) -

Malaysia - Inggris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

f.e. venture sdn. bhd. - toltrazuril -

Amerika Serikat - Inggris - NLM (National Library of Medicine)

merck sharp & dohme corp. - diclazuril (unii: k110k1b1ve) (diclazuril - unii:k110k1b1ve) - diclazuril 16 g in 1 kg - protazil® (1.56% diclazuril) antiprotozoal pellets are indicated for the treatment of equine protozoal myeloencephalitis (epm) caused by sarcocystis neurona in horses. use of protazil® (1.56% diclazuril) antiprotozoal pellets is contraindicated in horses with known hypersensitivity to diclazuril.